Grape King Bio Ltd (TPE:1707)
Taiwan · Delayed Price · Currency is TWD 121.00
-0.50 (-0.41%)
Feb 2, 2026, 1:35 PM CST
Grape King Bio Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 1,220 | 1,448 | 1,453 | 1,457 | 1,300 | 1,272 |
Depreciation & Amortization | 547.25 | 513.48 | 459.76 | 435.59 | 416.63 | 405 |
Other Amortization | 3.11 | - | - | 14.05 | 10.83 | 10 |
Loss (Gain) From Sale of Assets | 0.13 | -0.62 | 1.07 | -3.76 | -0.82 | 0.48 |
Loss (Gain) From Sale of Investments | -0.48 | -0.9 | -0.42 | 1.91 | -0.8 | - |
Loss (Gain) on Equity Investments | -23.44 | -22.24 | -19.87 | -10.82 | -2.23 | -1.68 |
Stock-Based Compensation | - | - | - | - | - | 2.49 |
Provision & Write-off of Bad Debts | - | 0.03 | -0.77 | - | 0.37 | 4.84 |
Other Operating Activities | 1,024 | -17.21 | 716.87 | 828.21 | 854.08 | 1,069 |
Change in Accounts Receivable | -123.35 | -12.82 | -16.49 | 31.05 | -99.37 | 0.37 |
Change in Inventory | -18.13 | -62.13 | 17.36 | 9.45 | -29.79 | -143.02 |
Change in Accounts Payable | 3.14 | 19.34 | -7.81 | 24.88 | 13.65 | 32.69 |
Change in Unearned Revenue | 6 | -7.63 | -53.98 | 44.22 | 32.93 | 31.23 |
Change in Other Net Operating Assets | -420.06 | 18.3 | -29.04 | 158.55 | 46.32 | 35.56 |
Operating Cash Flow | 2,218 | 1,876 | 2,519 | 2,990 | 2,542 | 2,719 |
Operating Cash Flow Growth | -4.10% | -25.54% | -15.75% | 17.63% | -6.51% | 25.22% |
Capital Expenditures | -468.69 | -626.71 | -587.18 | -486.69 | -275.2 | -1,214 |
Sale of Property, Plant & Equipment | 0.2 | 0.89 | 0 | 0.02 | 0.01 | 0.96 |
Cash Acquisitions | - | - | -29.9 | - | - | - |
Sale (Purchase) of Intangibles | -20.59 | -21.19 | -14.21 | -15.78 | -3.2 | -12.38 |
Sale (Purchase) of Real Estate | - | -4.09 | - | 40.18 | 0.66 | - |
Investment in Securities | -90.02 | -12.95 | -25.34 | 129.69 | -194.38 | 4.04 |
Other Investing Activities | -3.6 | 1.94 | 1.9 | 2.27 | 9.77 | -6.25 |
Investing Cash Flow | -574.26 | -662.11 | -654.73 | -330.31 | -462.34 | -1,227 |
Short-Term Debt Issued | - | - | 50 | 205 | - | 2,350 |
Long-Term Debt Issued | - | - | 0.1 | 0.1 | - | 873 |
Total Debt Issued | - | - | 50.1 | 205.1 | - | 3,223 |
Short-Term Debt Repaid | - | - | -50 | -205 | -500 | -2,200 |
Long-Term Debt Repaid | - | -54.96 | -49.97 | -140.06 | -1,371 | -327.24 |
Total Debt Repaid | -66.14 | -54.96 | -99.97 | -345.06 | -1,871 | -2,527 |
Net Debt Issued (Repaid) | -66.14 | -54.96 | -49.87 | -139.96 | -1,871 | 695.76 |
Issuance of Common Stock | - | - | - | - | 2,015 | 44.62 |
Common Dividends Paid | -1,022 | -1,022 | -1,022 | -903.64 | -948.08 | -884.21 |
Other Financing Activities | -652.2 | -640.28 | -636.92 | -584.95 | -564.59 | -578.97 |
Financing Cash Flow | -1,740 | -1,717 | -1,709 | -1,629 | -1,369 | -722.8 |
Foreign Exchange Rate Adjustments | -45.09 | 27.48 | -9.89 | 6.08 | -2.68 | 11.8 |
Net Cash Flow | -141.89 | -476.1 | 145.85 | 1,038 | 708.17 | 780.82 |
Free Cash Flow | 1,749 | 1,249 | 1,932 | 2,504 | 2,267 | 1,505 |
Free Cash Flow Growth | 8.44% | -35.35% | -22.83% | 10.44% | 50.59% | -2.31% |
Free Cash Flow Margin | 16.81% | 11.19% | 18.17% | 24.09% | 23.14% | 16.42% |
Free Cash Flow Per Share | 11.73 | 8.38 | 12.96 | 16.80 | 15.28 | 11.00 |
Cash Interest Paid | 0.14 | 0.07 | 0.07 | 0.2 | 2.64 | 11.74 |
Cash Income Tax Paid | 76.54 | 1,233 | 469.81 | 423.46 | 262.29 | 39.11 |
Levered Free Cash Flow | 1,141 | 1,009 | 1,285 | 2,044 | 1,800 | 990.83 |
Unlevered Free Cash Flow | 1,143 | 1,011 | 1,287 | 2,045 | 1,802 | 999.73 |
Change in Working Capital | -552.41 | -44.93 | -89.96 | 268.15 | -36.27 | -43.18 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.